In connection with the implementation of the project titled “Design and development of nanoparticle-RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids”, by BS Biotechna SA, under contract no. 2022/ABM/06/00005-00 for co-financing of a commercial project as part of the Development Competition targeted or personalized medicine based on medicinal products based on nucleic acids and small-molecule compounds. The Ordering Party conducts market research regarding the costs of delivery and purchase of substrate, cell lines, reagents and accessories necessary for research and development purposes.
W celu złożenia oferty prosimy o zapoznanie się ze szczegółową treścią ogłoszenia zamieszczoną w „dostawie” oraz o przesłanie wypełnionego formularza ofertowego i formularza asortymentowo – cenowego (Excel).